Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05124873 · ClinicalTrials.gov registry record · NA

Moisture Management Liner At-Home Evaluation

A NA study, sponsored by Liberating Technologies.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT05124873: Clinical Trial NA study, sponsored by Liberating Technologies.

NCT05124873 is a NA study that was terminated before completion, run by Liberating Technologies. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05124873, a NA study, was terminated before completion, sponsored by Liberating Technologies.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

The comfort and fit of the residual limb within a prosthetic socket are of primary concern for many amputees. The residual limb is typically covered by unbreathable and non-thermally conductive materials that can create a warm and ultimately moist environment. The investigators have developed a silicone liner approach to passively conduct heat from the skin using thermally conductive elastomers. A technology that can provide thermal control while retaining adequate suspension, weight, and other prosthetic characteristics would benefit many prosthesis wearers.

Primary Outcome

The modified Dermatology Life Quality Index (mDLQI) is a modified version of the Dermatology Life Quality Index (DLQI). The DLQI is a simple questionnaire designed to measure the health-related quality of life of adult patients suffering from various skin diseases. A modified version of the questionnaire (mDLQI) was developed to be more directly applicable to persons with amputation (i.e., revised wording to apply to the skin on their residual limb). The modified survey is scored from 0 to 27, w

Interventions

  • DEVICE Moisture Management Liner

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2021-05-12
Est. Completion 2022-09-27
Phase NA
Liberating Technologies

13 total trials

Why NCT05124873 stopped before completion

NCT05124873 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Moisture Management Liner is the first listed.

NCT05124873 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05124873 about?

NCT05124873 is a clinical study titled "Moisture Management Liner At-Home Evaluation". The comfort and fit of the residual limb within a prosthetic socket are of primary concern for many amputees. The residual limb is typically covered by unbreathable and non-thermally conductive materials that can create a warm and ultimately moist environment. The investigators have developed a sil...

What is the current status of trial NCT05124873?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2021-05-12. Estimated completion is 2022-09-27.

What interventions are being tested in trial NCT05124873?

The interventions under investigation include: Moisture Management Liner (DEVICE).

Who is sponsoring clinical trial NCT05124873?

This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05124873's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05124873, the US trial registry maintained by the National Library of Medicine. NCT05124873 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.